Literature DB >> 29729390

Advances in microstructural diffusion neuroimaging for psychiatric disorders.

Ofer Pasternak1, Sinead Kelly2, Valerie J Sydnor3, Martha E Shenton4.   

Abstract

Understanding the neuropathological underpinnings of mental disorders such as schizophrenia, major depression, and bipolar disorder is an essential step towards the development of targeted treatments. Diffusion MRI studies utilizing the diffusion tensor imaging (DTI) model have been extremely successful to date in identifying microstructural brain abnormalities in individuals suffering from mental illness, especially in regions of white matter, although identified abnormalities have been biologically non-specific. Building on DTI's success, in recent years more advanced diffusion MRI methods have been developed and applied to the study of psychiatric populations, with the aim of offering increased sensitivity to subtle neurological abnormalities, as well as improved specificity to candidate pathologies such as demyelination and neuroinflammation. These advanced methods, however, usually come at the cost of prolonged imaging sequences or reduced signal to noise, and they are more difficult to evaluate compared with the more simplified approach taken by the now common DTI model. To date, a limited number of advanced diffusion MRI methods have been employed to study schizophrenia, major depression and bipolar disorder populations. In this review we survey these studies, compare findings across diverse methods, discuss the main benefits and limitations of the different methods, and assess the extent to which the application of more advanced diffusion imaging approaches has led to novel and transformative information with regards to our ability to better understand the etiology and pathology of mental disorders.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bipolar disorder; Diffusion MRI; Major depression; Microstructure; Schizophrenia

Mesh:

Year:  2018        PMID: 29729390      PMCID: PMC6420686          DOI: 10.1016/j.neuroimage.2018.04.051

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  24 in total

1.  Diffusion abnormalities in the corpus callosum in first episode schizophrenia: Associated with enlarged lateral ventricles and symptomatology.

Authors:  Elisabetta C Del Re; Sylvain Bouix; Jennifer Fitzsimmons; Gabriëlla A M Blokland; Raquelle Mesholam-Gately; Joanne Wojcik; Zora Kikinis; Marek Kubicki; Tracey Petryshen; Ofer Pasternak; Martha E Shenton; Margaret Niznikiewicz
Journal:  Psychiatry Res       Date:  2019-02-18       Impact factor: 3.222

2.  Fast and accurate initialization of the free-water imaging model parameters from multi-shell diffusion MRI.

Authors:  Ørjan Bergmann; Rafael Henriques; Carl-Fredrik Westin; Ofer Pasternak
Journal:  NMR Biomed       Date:  2019-12-19       Impact factor: 4.044

3.  Clinical translational neuroimaging of the antioxidant effect of N-acetylcysteine on neural microstructure.

Authors:  Sue Y Yi; Brian R Barnett; McKenzie J Poetzel; Nicholas A Stowe; John-Paul J Yu
Journal:  Magn Reson Med       Date:  2021-09-30       Impact factor: 4.668

4.  Test-retest reliability and long-term stability of three-tissue constrained spherical deconvolution methods for analyzing diffusion MRI data.

Authors:  Benjamin T Newman; Thijs Dhollander; Kristen A Reynier; Matthew B Panzer; T Jason Druzgal
Journal:  Magn Reson Med       Date:  2020-02-28       Impact factor: 4.668

Review 5.  Neuroimaging in Schizophrenia.

Authors:  Matcheri S Keshavan; Guusje Collin; Synthia Guimond; Sinead Kelly; Konasale M Prasad; Paulo Lizano
Journal:  Neuroimaging Clin N Am       Date:  2019-11-11       Impact factor: 2.264

6.  Brain free water alterations in first-episode psychosis: a longitudinal analysis of diagnosis, course of illness, and medication effects.

Authors:  J Y Guo; T A Lesh; T A Niendam; J D Ragland; L M Tully; C S Carter
Journal:  Psychol Med       Date:  2020-01-08       Impact factor: 7.723

7.  The clinical relevance of gray matter atrophy and microstructural brain changes across the psychosis continuum.

Authors:  Faith M Hanlon; Andrew B Dodd; Josef M Ling; Nicholas A Shaff; David D Stephenson; Juan R Bustillo; Shannon F Stromberg; Denise S Lin; Sephira G Ryman; Andrew R Mayer
Journal:  Schizophr Res       Date:  2021-02-17       Impact factor: 4.939

8.  A 16-week randomized placebo-controlled trial investigating the effects of omega-3 polyunsaturated fatty acid treatment on white matter microstructure in recent-onset psychosis patients concurrently treated with risperidone.

Authors:  Amanda E Lyall; Felix L Nägele; Ofer Pasternak; Juan A Gallego; Anil K Malhotra; Robert K McNamara; Marek Kubicki; Bart D Peters; Delbert G Robinson; Philip R Szeszko
Journal:  Psychiatry Res Neuroimaging       Date:  2020-11-04       Impact factor: 2.376

9.  Cellular and extracellular white matter alterations indicate conversion to psychosis among individuals at clinical high-risk for psychosis.

Authors:  Felix L Nägele; Ofer Pasternak; Lisa V Bitzan; Marius Mußmann; Jonas Rauh; Marek Kubicki; Gregor Leicht; Martha E Shenton; Amanda E Lyall; Christoph Mulert
Journal:  World J Biol Psychiatry       Date:  2020-07-09       Impact factor: 4.132

10.  Effect of DAOA genetic variation on white matter alteration in corpus callosum in patients with first-episode schizophrenia.

Authors:  Wenjun Su; Tianyuan Zhu; Lihua Xu; Yanyan Wei; Botao Zeng; Tianhong Zhang; Huiru Cui; Junjie Wang; Yuping Jia; Jinhong Wang; Donald C Goff; Yingying Tang; Jijun Wang
Journal:  Brain Imaging Behav       Date:  2021-08       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.